rethinkPeptides Search
Menu
Study breakdown

New Chemistry Method Makes It Easier to Build Ring-Shaped Antimicrobial Peptides

MethodologyPreliminary evidence
The takeaway

A new solid-phase synthesis strategy builds ring-shaped peptides with a reactive backbone amine, enabling efficient production of lipidated cyclic and bicyclic antimicrobial peptides.

3- to 13-mer macrocycles

The method works across a wide range of peptide ring sizes using standard synthesis equipment

What the researchers found

Researchers developed a new way to build ring-shaped (macrocyclic) peptides directly on solid-phase synthesis supports. The key innovation is that the ring closure creates a secondary amine in the peptide backbone that remains chemically reactive — meaning you can keep building on the peptide after cyclization. This enabled the synthesis of both cyclic and bicyclic peptides ranging from 3 to 13 amino acids, and the method was demonstrated by making lipidated antimicrobial peptide variants.

Why it matters

Cyclic peptides are more drug-like than linear ones — they're more stable, more selective, and better at crossing cell membranes. But making them is hard, especially when you want to add lipid chains (lipidation) that further improve drug properties. This method solves that problem by leaving a reactive handle inside the ring that allows further chemistry. It could accelerate the development of next-generation antimicrobial peptides and other cyclic peptide drugs.

The numbers in context

3- to 13-mer macrocycles · compatible with standard Fmoc/tBu SPPS · cyclic and bicyclic peptides produced · lipidated antimicrobial peptide variants demonstrated

How the study worked

Organic chemistry method development. The researchers used intramolecular halide substitution by a diamino acid during standard solid-phase peptide synthesis (Fmoc/tBu SPPS) to form macrocyclic peptides. The resulting endocyclic secondary amine was then acylated to continue synthesis, producing lipidated cyclic and bicyclic antimicrobial peptides.

Who was studied

Not applicable (chemical synthesis methodology study)

What this study cannot tell us

This is a synthesis methodology paper — no biological activity data is presented for the antimicrobial peptides produced. The approach was demonstrated on a limited range of peptide sizes. Scalability and compatibility with all amino acid sequences were not fully explored.

How to read the evidence

Preliminary — this is a chemistry methodology paper demonstrating a new synthesis approach. While the chemistry works, no biological testing of the resulting peptides is reported. The value lies in enabling future biological studies, not in direct therapeutic evidence.

When this study was published

Published in 2015. The cyclic peptide synthesis field has continued to advance, but the core approach described here — on-resin macrocyclization with a reactive backbone amine — remains a useful strategy in the peptide chemist's toolkit.

The bigger picture

The growing crisis of antibiotic resistance has pushed researchers toward antimicrobial peptides as alternatives to traditional antibiotics. But turning these peptides into viable drugs requires making them more stable and potent — which often means cyclization and lipidation. This synthesis method removes a major bottleneck in that process, potentially enabling medicinal chemists to rapidly explore libraries of cyclic and bicyclic antimicrobial peptide variants to find the best drug candidates.

Questions still open

  • How do the lipidated cyclic antimicrobial peptides produced by this method perform against drug-resistant bacteria?
  • Can this synthesis approach scale to produce the quantities needed for preclinical testing?
  • Does the endocyclic secondary amine affect the biological activity or stability of the final peptide products?

Common questions

Why are ring-shaped peptides better as drugs than straight-chain ones?
Ring-shaped (cyclic) peptides are more resistant to breakdown by enzymes in the body, can be more selective for their targets, and sometimes cross cell membranes more easily. These properties make them more 'drug-like' — they last longer in the body and work at lower doses. Many successful peptide drugs, including cyclosporine, are cyclic.
What does lipidation do for antimicrobial peptides?
Adding a lipid (fat-like) chain to an antimicrobial peptide can improve how it interacts with bacterial membranes — which is how these peptides kill bacteria. Lipidation can also make the peptide last longer in the body and increase its potency. This study's method makes it easier to add lipid chains to cyclic peptides during manufacturing.

Read the original research

Peptide macrocycles featuring a backbone secondary amine: a convenient strategy for the synthesis of lipidated cyclic and bicyclic peptides on solid support.

Organic letters, 17(10), 2502-5

Citation

Oddo, Alberto; Münzker, Lena; Hansen, Paul R. (2015). Peptide macrocycles featuring a backbone secondary amine: a convenient strategy for the synthesis of lipidated cyclic and bicyclic peptides on solid support.. Organic letters, 17(10), 2502-5. https://doi.org/10.1021/acs.orglett.5b01026